CA
NZ
UK
AU
IND
US
Fathom Holdings has restructured its payment terms, converting a single deferred payment into a three-part installment plan. The amendment follows the original agreement that required a payment of $3.0 million from the purchaser.
Figure Technology Solutions disclosed plans to raise $600 million through a private placement of senior notes set to mature in 2031. The offering, finalized on July 6, 2026, is subject to market conditions and customary closing requirements. Proceeds will primarily finance the company’s acquisition …
Incyte (NASDAQ: INCY) has closed its purchase of Vega Therapeutics, a strategic step intended to reinforce its late‑stage development portfolio. The agreement, first announced earlier in the year, positions the company to broaden its reach in hematology and rare‑disease therapeutics.
Ingredion (NYSE: INGR) has taken a critical step toward completing its acquisition of Tate & Lyle, releasing the formal scheme document that details the structure of the deal. The announcement sets the stage for shareholder endorsement, a pivotal milestone in the all‑cash transaction.
Ingredion (NYSE: INGR) has taken a critical step toward completing its acquisition of Tate & Lyle, releasing the formal scheme document that details the structure of the deal. The announcement sets the stage for shareholder endorsement, a pivotal milestone in the all‑cash transaction.
Jet.AI Inc. (NASDAQ: JTAI) reported that shareholders have given their consent to the planned combination with flyExclusive after a sequence of special meetings. The decisive ballot on July 2, 2026, satisfied the statutory majority requirement.
Cemtrex (NASDAQ: CETX) has strengthened its Industrial Services segment with the acquisition of Plant Engineering Services, a move aimed at expanding its operational footprint. The deal, completed through its subsidiary Advanced Industrial Services, marks a strategic push into new revenue streams.
Clarivate Plc (NYSE: CLVT) disclosed that subsidiaries have executed a Stock and Asset Purchase Agreement with an Altaris, LLC affiliate to transfer its Life Sciences & Healthcare segment. The agreement, signed on July 3 2026, outlines a transaction valued at $600,000,000 and is slated …
CoreCivic, Inc. (NYSE: CXW) has completed two significant sales of its detention facilities worth around $1.5 billion combined. The transactions, finalized on July 2, 2026, involved the sale of the California City Detention Facility and the Otay Mesa Detention Center, both of which are …
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) entered into a definitive merger agreement with Crinetics Pharmaceuticals Inc. (NASDAQ: CRNX) on July 6, 2026. The transaction will make Crinetics a wholly owned subsidiary of Vertex, with closing anticipated in early 2027.
Please wait processing your request...